Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 127

1.

Synthesis and biological evaluation of PSMA-targeting paclitaxel conjugates.

Machulkin AE, Skvortsov DA, Ivanenkov YA, Ber AP, Kavalchuk MV, Aladinskaya AV, Uspenskaya AA, Shafikov RR, Plotnikova EA, Yakubovskaya RI, Nimenko EA, Zyk NU, Beloglazkina EK, Zyk NV, Koteliansky VE, Majouga AG.

Bioorg Med Chem Lett. 2019 Aug 15;29(16):2229-2235. doi: 10.1016/j.bmcl.2019.06.035. Epub 2019 Jun 20.

PMID:
31248772
2.

Corrigendum to 'Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA' [Bioor. Med. Chem. Lett. 29/10 (2019) 1246-1255].

Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Ryabykh GK, Sofronova AA, Malyshev AS, Majouga AG.

Bioorg Med Chem Lett. 2019 Jul 1;29(13):1688. doi: 10.1016/j.bmcl.2019.04.038. Epub 2019 May 2. No abstract available.

PMID:
31056242
3.

Synthesis and biological evaluation of Doxorubicin-containing conjugate targeting PSMA.

Ivanenkov YA, Machulkin AE, Garanina AS, Skvortsov DA, Uspenskaya AA, Deyneka EV, Trofimenko AV, Beloglazkina EK, Zyk NV, Koteliansky VE, Bezrukov DS, Aladinskaya AV, Vorobyeva NS, Puchinina MM, Riabykh GK, Sofronova AA, Malyshev AS, Majouga AG.

Bioorg Med Chem Lett. 2019 May 15;29(10):1246-1255. doi: 10.1016/j.bmcl.2019.01.040. Epub 2019 Feb 1. Erratum in: Bioorg Med Chem Lett. 2019 Jul 1;29(13):1688.

PMID:
30904185
4.

mRNA-Based Therapeutics - Advances and Perspectives.

Sergeeva OV, Koteliansky VE, Zatsepin TS.

Biochemistry (Mosc). 2016 Jul;81(7):709-22. doi: 10.1134/S0006297916070075. Review.

5.

Identification of Novel Small-Molecule ASGP-R Ligands.

Majouga AG, Ivanenkov YA, Veselov MS, Lopuhov AV, Maklakova SV, Beloglazkina EK, Binevski PV, Klyachko NL, Sandulenko YB, Galkina NY, Koteliansky VE.

Curr Drug Deliv. 2016;13(8):1303-1312.

PMID:
27440073
6.

Small-molecule PSMA ligands. Current state, SAR and perspectives.

Machulkin AE, Ivanenkov YA, Aladinskaya AV, Veselov MS, Aladinskiy VA, Beloglazkina EK, Koteliansky VE, Shakhbazyan AG, Sandulenko YB, Majouga AG.

J Drug Target. 2016 Sep;24(8):679-93. doi: 10.3109/1061186X.2016.1154564. Epub 2016 Mar 10. Review.

PMID:
26887438
7.

Synthesis, isomerization and biological activity of novel 2-selenohydantoin derivatives.

Ivanenkov YA, Veselov MS, Rezekin IG, Skvortsov DA, Sandulenko YB, Polyakova MV, Bezrukov DS, Vasilevsky SV, Kukushkin ME, Moiseeva AA, Finko AV, Koteliansky VE, Klyachko NL, Filatova LA, Beloglazkina EK, Zyk NV, Majouga AG.

Bioorg Med Chem. 2016 Feb 15;24(4):802-11. doi: 10.1016/j.bmc.2015.12.050. Epub 2016 Jan 2.

PMID:
26780833
8.

N6-Methylated Adenosine in RNA: From Bacteria to Humans.

Sergiev PV, Golovina AY, Osterman IA, Nesterchuk MV, Sergeeva OV, Chugunova AA, Evfratov SA, Andreianova ES, Pletnev PI, Laptev IG, Petriukov KS, Navalayeu TI, Koteliansky VE, Bogdanov AA, Dontsova OA.

J Mol Biol. 2016 May 22;428(10 Pt B):2134-45. doi: 10.1016/j.jmb.2015.12.013. Epub 2015 Dec 19. Review.

PMID:
26707202
9.

A Comprehensive Insight into the Chemical Space and ADME Features of Small Molecule NS5A Inhibitors.

Ivanenkov YA, Veselov MS, Shakhbazyan AG, Aladinskiy VA, Aladinskaya AV, Yartseva SM, Majouga AG, Vantskul AS, Leonov SV, Ivachtchenko AV, Koteliansky VE.

Curr Top Med Chem. 2016;16(12):1372-82. Review.

PMID:
26585933
10.

In Silico Approaches to the Design of NS5A Inhibitors.

Ivanenkov YA, Veselov MS, Aladinskiy VA, Shakhbazyan AG, Yartseva SM, Majouga AG, Aladinskaya AV, Vantskul AS, Leonov SV, Ivachtchenko AV, Koteliansky VE.

Curr Top Med Chem. 2016;16(12):1383-91. Review.

PMID:
26585932
11.

A monoclonal antibody to alpha1beta1 blocks antigen-induced airway responses in sheep.

Abraham WM, Ahmed A, Serebriakov I, Carmillo AN, Ferrant J, de Fougerolles AR, Garber EA, Gotwals PJ, Koteliansky VE, Taylor F, Lobb RR.

Am J Respir Crit Care Med. 2004 Jan 1;169(1):97-104. Epub 2003 Oct 24.

PMID:
14578216
12.

A dual role for Sonic hedgehog in regulating adhesion and differentiation of neuroepithelial cells.

Jarov A, Williams KP, Ling LE, Koteliansky VE, Duband JL, Fournier-Thibault C.

Dev Biol. 2003 Sep 15;261(2):520-36.

13.

Expression and functional importance of collagen-binding integrins, alpha 1 beta 1 and alpha 2 beta 1, on virus-activated T cells.

Andreasen SØ, Thomsen AR, Koteliansky VE, Novobrantseva TI, Sprague AG, de Fougerolles AR, Christensen JP.

J Immunol. 2003 Sep 15;171(6):2804-11.

14.

Cell and molecular regulation of endothelin-1 production during hepatic wound healing.

Shao R, Shi Z, Gotwals PJ, Koteliansky VE, George J, Rockey DC.

Mol Biol Cell. 2003 Jun;14(6):2327-41. Epub 2003 Apr 17.

15.

Functional overlap and cooperativity among alphav and beta1 integrin subfamilies during skin angiogenesis.

Perruzzi CA, de Fougerolles AR, Koteliansky VE, Whelan MC, Westlin WF, Senger DR.

J Invest Dermatol. 2003 Jun;120(6):1100-9.

16.

Transforming growth factor-beta-dependent events in vascular remodeling following arterial injury.

Ryan ST, Koteliansky VE, Gotwals PJ, Lindner V.

J Vasc Res. 2003 Jan-Feb;40(1):37-46.

PMID:
12644724
17.

Collagen-binding integrin alpha1beta1 regulates intestinal inflammation in experimental colitis.

Krieglstein CF, Cerwinka WH, Sprague AG, Laroux FS, Grisham MB, Koteliansky VE, Senninger N, Granger DN, de Fougerolles AR.

J Clin Invest. 2002 Dec;110(12):1773-82.

18.

Importance of innate immunity and collagen binding integrin alpha1beta1 in TNBS-induced colitis.

Fiorucci S, Mencarelli A, Palazzetti B, Sprague AG, Distrutti E, Morelli A, Novobrantseva TI, Cirino G, Koteliansky VE, de Fougerolles AR.

Immunity. 2002 Dec;17(6):769-80.

19.

Interference with TGF-beta1 and -beta3 in tumor stroma lowers tumor interstitial fluid pressure independently of growth in experimental carcinoma.

Lammerts E, Roswall P, Sundberg C, Gotwals PJ, Koteliansky VE, Reed RK, Heldin NE, Rubin K.

Int J Cancer. 2002 Dec 10;102(5):453-62.

20.

Regulation of monocyte gene expression by the extracellular matrix and its functional implications.

de Fougerolles AR, Koteliansky VE.

Immunol Rev. 2002 Aug;186:208-20. Review.

PMID:
12234373
21.

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression.

Lutgens E, Gijbels M, Smook M, Heeringa P, Gotwals P, Koteliansky VE, Daemen MJ.

Arterioscler Thromb Vasc Biol. 2002 Jun 1;22(6):975-82.

PMID:
12067907
22.

The EIIIA segment of fibronectin is a ligand for integrins alpha 9beta 1 and alpha 4beta 1 providing a novel mechanism for regulating cell adhesion by alternative splicing.

Liao YF, Gotwals PJ, Koteliansky VE, Sheppard D, Van De Water L.

J Biol Chem. 2002 Apr 26;277(17):14467-74. Epub 2002 Feb 11.

23.
24.

Sonic hedgehog restricts adhesion and migration of neural crest cells independently of the Patched- Smoothened-Gli signaling pathway.

Testaz S, Jarov A, Williams KP, Ling LE, Koteliansky VE, Fournier-Thibault C, Duband JL.

Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12521-6. Epub 2001 Oct 9.

25.

TGF-beta is a critical mediator of acute lung injury.

Pittet JF, Griffiths MJ, Geiser T, Kaminski N, Dalton SL, Huang X, Brown LA, Gotwals PJ, Koteliansky VE, Matthay MA, Sheppard D.

J Clin Invest. 2001 Jun;107(12):1537-44.

26.

Global expression analysis of extracellular matrix-integrin interactions in monocytes.

de Fougerolles AR, Chi-Rosso G, Bajardi A, Gotwals P, Green CD, Koteliansky VE.

Immunity. 2000 Dec;13(6):749-58.

27.

Recombinant soluble transforming growth factor beta type II receptor ameliorates radiation enteropathy in mice.

Zheng H, Wang J, Koteliansky VE, Gotwals PJ, Hauer-Jensen M.

Gastroenterology. 2000 Nov;119(5):1286-96.

PMID:
11054386
28.

Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype.

Lutgens E, Cleutjens KB, Heeneman S, Koteliansky VE, Burkly LC, Daemen MJ.

Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7464-9.

29.

Regulation of inflammation by collagen-binding integrins alpha1beta1 and alpha2beta1 in models of hypersensitivity and arthritis.

de Fougerolles AR, Sprague AG, Nickerson-Nutter CL, Chi-Rosso G, Rennert PD, Gardner H, Gotwals PJ, Lobb RR, Koteliansky VE.

J Clin Invest. 2000 Mar;105(6):721-9.

30.

Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.

George J, Wang SS, Sevcsik AM, Sanicola M, Cate RL, Koteliansky VE, Bissell DM.

Am J Pathol. 2000 Jan;156(1):115-24.

31.

Requirement for CD154 in the progression of atherosclerosis.

Lutgens E, Gorelik L, Daemen MJ, de Muinck ED, Grewal IS, Koteliansky VE, Flavell RA.

Nat Med. 1999 Nov;5(11):1313-6.

PMID:
10546000
32.
33.

Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.

Wang Q, Wang Y, Hyde DM, Gotwals PJ, Koteliansky VE, Ryan ST, Giri SN.

Thorax. 1999 Sep;54(9):805-12.

34.

Soluble transforming growth factor-beta type II receptor inhibits negative remodeling, fibroblast transdifferentiation, and intimal lesion formation but not endothelial growth.

Smith JD, Bryant SR, Couper LL, Vary CP, Gotwals PJ, Koteliansky VE, Lindner V.

Circ Res. 1999 May 28;84(10):1212-22.

PMID:
10347096
35.

Integrins inhibit angiotensin II-induced contraction in rat aortic rings.

Schnapp LM, Goswami S, Rienzi N, Koteliansky VE, Gotwals P, Schachter EN.

Regul Pept. 1998 Oct 16;77(1-3):177-83.

PMID:
9809813
36.

Differential onset of expression of alpha 7 and beta 1D integrins during mouse heart and skeletal muscle development.

Brancaccio M, Cabodi S, Belkin AM, Collo G, Koteliansky VE, Tomatis D, Altruda F, Silengo L, Tarone G.

Cell Adhes Commun. 1998 Mar;5(3):193-205.

PMID:
9686317
37.

A comparative molecular analysis of four rat smooth muscle cell lines.

Firulli AB, Han D, Kelly-Roloff L, Koteliansky VE, Schwartz SM, Olson EN, Miano JM.

In Vitro Cell Dev Biol Anim. 1998 Mar;34(3):217-26.

PMID:
9557939
38.

Muscle beta1D integrin reinforces the cytoskeleton-matrix link: modulation of integrin adhesive function by alternative splicing.

Belkin AM, Retta SF, Pletjushkina OY, Balzac F, Silengo L, Fassler R, Koteliansky VE, Burridge K, Tarone G.

J Cell Biol. 1997 Dec 15;139(6):1583-95.

39.

Fibronectin type III repeats mediate RGD-independent adhesion and signaling through activated beta1 integrins.

Chi-Rosso G, Gotwals PJ, Yang J, Ling L, Jiang K, Chao B, Baker DP, Burkly LC, Fawell SE, Koteliansky VE.

J Biol Chem. 1997 Dec 12;272(50):31447-52.

40.

Cytokeratin expression in human arteries pertinent to intimal thickening formation in the ductus arteriosus.

Slomp J, Gittenberger-de Groot AC, Koteliansky VE, Glukhova MA, Bogers AJ, Poelmann RE.

Differentiation. 1997 Aug;61(5):305-11.

PMID:
9342841
41.

Differentiation, dedifferentiation, and apoptosis of smooth muscle cells during the development of the human ductus arteriosus.

Slomp J, Gittenberger-de Groot AC, Glukhova MA, Conny van Munsteren J, Kockx MM, Schwartz SM, Koteliansky VE.

Arterioscler Thromb Vasc Biol. 1997 May;17(5):1003-9.

PMID:
9157967
42.

The alpha1beta1 integrin is expressed during neointima formation in rat arteries and mediates collagen matrix reorganization.

Gotwals PJ, Chi-Rosso G, Lindner V, Yang J, Ling L, Fawell SE, Koteliansky VE.

J Clin Invest. 1996 Jun 1;97(11):2469-77.

43.

A novel dystrophin/utrophin-associated protein is an enzymatically inactive member of the phosphoglucomutase superfamily.

Moiseeva EP, Belkin AM, Spurr NK, Koteliansky VE, Critchley DR.

Eur J Biochem. 1996 Jan 15;235(1-2):103-13.

44.

Beta 1D integrin displaces the beta 1A isoform in striated muscles: localization at junctional structures and signaling potential in nonmuscle cells.

Belkin AM, Zhidkova NI, Balzac F, Altruda F, Tomatis D, Maier A, Tarone G, Koteliansky VE, Burridge K.

J Cell Biol. 1996 Jan;132(1-2):211-26.

45.

Contractility and phenotype transitions in serosal thickening of obstructed rabbit bladder.

Roelofs M, Wein AJ, Monson FC, Passerini-Glazel G, Koteliansky VE, Sartore S, Levin RM.

J Appl Physiol (1985). 1995 Apr;78(4):1432-41.

PMID:
7615452
47.

Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis.

Jarnagin WR, Rockey DC, Koteliansky VE, Wang SS, Bissell DM.

J Cell Biol. 1994 Dec;127(6 Pt 2):2037-48.

48.

Expression of beta 1B integrin isoform in CHO cells results in a dominant negative effect on cell adhesion and motility.

Balzac F, Retta SF, Albini A, Melchiorri A, Koteliansky VE, Geuna M, Silengo L, Tarone G.

J Cell Biol. 1994 Oct;127(2):557-65.

49.
50.

Phenotypic changes of human aortic smooth muscle cells during development and in adult.

Glukhova MA, Frid MG, Koteliansky VE.

J Atheroscler Thromb. 1994;1 Suppl 1:S47-9. No abstract available.

PMID:
9222891

Supplemental Content

Loading ...
Support Center